The Percutaneous Coronary Intervention (PCI) Device market is a segment of the Cardiovascular Devices market. It includes devices used to treat coronary artery disease, such as balloon catheters, stents, guidewires, and other accessories. These devices are used to open blocked arteries, restore blood flow, and reduce the risk of heart attack. PCI devices are minimally invasive, allowing for faster recovery times and fewer complications than traditional open-heart surgery. The PCI Device market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is further supported by government initiatives to reduce the burden of cardiovascular diseases and the increasing availability of healthcare services. Some of the major companies in the PCI Device market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, B. Braun Melsungen AG, Terumo Corporation, and Edwards Lifesciences Corporation. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
